Tirzepatide 30 mg — Research Peptide
Tirzepatide is a dual GIP/GLP-1 receptor agonist research peptide. The 30 mg vial provides an economical option for extended research protocols.
Product Details
- Net weight: 30 mg (lyophilised)
- Purity: ≥98.9% (HPLC-verified)
- Identity confirmed by LC-MS
- Batch-specific COA included
For research purposes only. Not intended for human use.
Reviews
There are no reviews yet.